CN101334344B - 从固体、半固体制剂中分离功效成分微粒的方法 - Google Patents
从固体、半固体制剂中分离功效成分微粒的方法 Download PDFInfo
- Publication number
- CN101334344B CN101334344B CN2007101268864A CN200710126886A CN101334344B CN 101334344 B CN101334344 B CN 101334344B CN 2007101268864 A CN2007101268864 A CN 2007101268864A CN 200710126886 A CN200710126886 A CN 200710126886A CN 101334344 B CN101334344 B CN 101334344B
- Authority
- CN
- China
- Prior art keywords
- sample
- water
- content
- particulate
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 239000007787 solid Substances 0.000 title claims abstract description 21
- 239000000203 mixture Substances 0.000 title description 19
- 238000009472 formulation Methods 0.000 title description 8
- 239000004615 ingredient Substances 0.000 title description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 85
- 239000002245 particle Substances 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 25
- 239000006071 cream Substances 0.000 claims abstract description 13
- 239000000829 suppository Substances 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 65
- 239000006228 supernatant Substances 0.000 claims description 51
- 238000010790 dilution Methods 0.000 claims description 50
- 239000012895 dilution Substances 0.000 claims description 50
- 239000013049 sediment Substances 0.000 claims description 48
- 239000000499 gel Substances 0.000 claims description 28
- 238000001556 precipitation Methods 0.000 claims description 25
- 230000010355 oscillation Effects 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 8
- 238000004458 analytical method Methods 0.000 abstract description 6
- 238000001514 detection method Methods 0.000 abstract description 6
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 235000015110 jellies Nutrition 0.000 abstract 1
- 238000000926 separation method Methods 0.000 description 45
- 238000013019 agitation Methods 0.000 description 37
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 26
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 26
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 25
- 238000012360 testing method Methods 0.000 description 25
- 241000180649 Panax notoginseng Species 0.000 description 23
- 235000003143 Panax notoginseng Nutrition 0.000 description 23
- 241000187654 Nocardia Species 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 16
- 238000012113 quantitative test Methods 0.000 description 16
- 239000002244 precipitate Substances 0.000 description 14
- 239000006185 dispersion Substances 0.000 description 12
- 229910052709 silver Inorganic materials 0.000 description 12
- 239000004332 silver Substances 0.000 description 12
- 238000000053 physical method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 241000169439 Nocar Species 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 6
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 244000131316 Panax pseudoginseng Species 0.000 description 4
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 4
- 238000013095 identification testing Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 208000008316 Arsenic Poisoning Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000004451 qualitative analysis Methods 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229910000474 mercury oxide Inorganic materials 0.000 description 1
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 244000062645 predators Species 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 239000012749 thinning agent Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 238000001132 ultrasonic dispersion Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
C项 | 红色诺卡氏菌细胞壁骨架原液 | 诺卡乳膏加原液150μl; |
样1 | 样2 | 样3 | 样4 | 空白 | |
龙骨粉含量(μg) | 400 | 200 | 100 | 20 | 0 |
龙骨粉乳膏含量(g) | 1 | 0.5 | 0.25 | 0.05 | 1 |
稀释倍数 | 20 | 25 | 30 | 100 | 10 |
样1 | 样2 | 样3 | 样4 | 空白 | |
纳米银含量(μg) | 350 | 175 | 87.5 | 17.5 | 0 |
纳米银凝胶含量(ml) | 1 | 0.5 | 0.25 | 0.05 | 1 |
稀释倍数 | 25 | 30 | 30 | 200 | 10 |
样1 | 样2 | 样3 | 样4 | 空白 | |
纳米银含量μg) | 350 | 175 | 87.5 | 17.5 | 0 |
纳米银凝胶含量(ml) | 1 | 0.5 | 0.25 | 0.05 | 1 |
稀释倍数 | 20 | 25 | 30 | 100 | 10 |
现象 | 白色絮状沉淀 | 白色絮状沉淀 | 白色絮状沉淀 | 白色絮状沉淀 | 无变化 |
样1 | 样2 | 样3 | 样4 | 空白 | |
纳米珍珠粉含量(μg) | 400 | 200 | 100 | 20 | 0 |
纳米珍珠粉乳膏含量 | 1 | 0.5 | 0.25 | 0.05 | 1 |
(g) | |||||
稀释倍数 | 20 | 25 | 30 | 100 | 10 |
样1 | 样2 | 样3 | 样4 | 空白 | |
三七粉含量(μg) | 400 | 200 | 100 | 20 | 0 |
三七粉乳膏含量(g) | 1 | 0.5 | 0.25 | 0.05 | 1 |
稀释倍数 | 20 | 25 | 20 | 150 | 10 |
样1 | 样2 | 样3 | 样4 | 空白 | |
赭石粉含量(μg) | 400 | 200 | 100 | 20 | 0 |
赭石粉乳膏含量(g) | 1 | 0.5 | 0.25 | 0.05 | 1 |
稀释倍数 | 15 | 25 | 30 | 100 | 10 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101268864A CN101334344B (zh) | 2007-06-29 | 2007-06-29 | 从固体、半固体制剂中分离功效成分微粒的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101268864A CN101334344B (zh) | 2007-06-29 | 2007-06-29 | 从固体、半固体制剂中分离功效成分微粒的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101334344A CN101334344A (zh) | 2008-12-31 |
CN101334344B true CN101334344B (zh) | 2010-12-15 |
Family
ID=40197087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101268864A Active CN101334344B (zh) | 2007-06-29 | 2007-06-29 | 从固体、半固体制剂中分离功效成分微粒的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101334344B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1289627A (zh) * | 1999-09-29 | 2001-04-04 | 中国科学院化工冶金研究所 | 药用植物有效成分的循环超声破碎浸提方法及装置 |
-
2007
- 2007-06-29 CN CN2007101268864A patent/CN101334344B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1289627A (zh) * | 1999-09-29 | 2001-04-04 | 中国科学院化工冶金研究所 | 药用植物有效成分的循环超声破碎浸提方法及装置 |
Also Published As
Publication number | Publication date |
---|---|
CN101334344A (zh) | 2008-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230213487A1 (en) | Fingerprint Detection Method for Pharmaceutical Preparation | |
Grubešić et al. | Spectrophotometric method for polyphenols analysis: Prevalidation and application on Plantago L. species | |
CN106501434B (zh) | 一种双和汤标准汤的hplc指纹图谱测定方法 | |
Dasgupta et al. | Herbal supplements: efficacy, toxicity, interactions with western drugs, and effects on clinical laboratory tests | |
CN106053700B (zh) | 一种首乌益智胶囊的指纹图谱测定方法 | |
CN109752478A (zh) | 一种复方透骨草制剂的中药指纹图谱检测方法 | |
CN107037146A (zh) | 一种复方木鸡颗粒质量控制的方法 | |
CN113466361A (zh) | 一种肠胃散的质量评价方法 | |
Li et al. | Speciation analysis of iron in traditional Chinese medicine by flame atomic absorption spectrometry | |
CN105021751B (zh) | 玉屏风制剂中多种成分的含量测定方法 | |
CN101334344B (zh) | 从固体、半固体制剂中分离功效成分微粒的方法 | |
CN110274978A (zh) | 一种芪参益气滴丸中三七多皂苷成分含量测定方法 | |
CN103675135B (zh) | 一种中药组合物的含量测定方法 | |
CN115479993B (zh) | 一种中成药质量一致性评价方法 | |
CN107884505A (zh) | 一种耳聋左慈丸指纹图谱的检测方法及其应用 | |
CN107884489A (zh) | 一种妇科再造丸的检测方法 | |
CN109799303B (zh) | 止血调经组合物的指纹图谱构建方法、定量检测方法及质量检测方法 | |
CN107941927B (zh) | 一种uplc/q-tof-ms测定党参炔苷含量的方法 | |
CN102353731A (zh) | 芪鹰颗粒的检测方法 | |
Li-Bing et al. | Application of chemomic release kinetics to evaluation of the release characteristics of Yinqiaojiedu tablets | |
Jing et al. | Effect of Ligustrum lucidum polysaccharide on immunity of immunosuppressed mice | |
CN109884164A (zh) | 益母草中无机元素的检测方法 | |
CN109358124A (zh) | 止血调经颗粒的质量检测方法 | |
CN105987978B (zh) | 一种同时测定香加皮中7种化合物含量的方法 | |
CN107655997A (zh) | 一种治疗慢性咽炎的中药组合物的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LIAONING NAKEJIA BIOLOGICAL PHARMACEUTICAL CO., LT Free format text: FORMER OWNER: SHANGHAI BAOYUAN TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130216 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130216 Address after: 110015 No. 7, Wen Dong Road, Shenhe District, Liaoning, Shenyang Patentee after: LIAONING NAKEJIA BIOPHARMACEUTICAL Co.,Ltd. Address before: 110015, No. 7, Wen Dong Road, Dongling District, Liaoning, Shenyang Patentee before: Shenyang Baoyuan Technology Development Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Hong Xiaoming Document name: Notification of Passing Examination on Formalities |
|
ASS | Succession or assignment of patent right |
Owner name: SHENYANG NAKEJIA BIO-TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LIAONING NAKEJIA BIOLOGICAL PHARMACEUTICAL CO., LTD. Effective date: 20150104 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 110015 SHENYANG, LIAONING PROVINCE TO: 117004 BENXI, LIAONING PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150104 Address after: 117004, No. 1, No. 1, 8-2, Ann street, Shiqiao village, Lake District, Benxi, Liaoning Patentee after: Shenyang treating biological technology Co.,Ltd. Address before: 110015 No. 7, Wen Dong Road, Shenhe District, Liaoning, Shenyang Patentee before: LIAONING NAKEJIA BIOPHARMACEUTICAL Co.,Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160801 Address after: 117000, No. 1, No. 1, 8-2, Chun An street, Shiqiao Town, Benxi, Liaoning Patentee after: LIAONING GREATEST BIO-PHARMACEUTICAL Co.,Ltd. Address before: 117004, No. 1, No. 1, 8-2, Ann street, Shiqiao village, Lake District, Benxi, Liaoning Patentee before: Shenyang treating biological technology Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 117000 No.1, 1st floor, building 8-2, Chun'an street, Shiqiaozi, Xihu District, Benxi City, Liaoning Province Patentee after: Liaoning Tian'an Biopharmaceutical Co.,Ltd. Address before: 117000 No.1, 1st floor, building 8-2, Chun'an street, Shiqiaozi, Xihu District, Benxi City, Liaoning Province Patentee before: LIAONING GREATEST BIO-PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |